Biotronik Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Available from:

BIOTRONIK ASIA PACIFIC PTE. LTD.

Class:

Class D (contains therapeutic product or medicinal product)

Manufactured by:

Biotronik AG

Therapeutic area:

Cardiovascular

Therapeutic indications:

is indicated for improving luminal diameter in the treatment of de novo native coronary artery lesions in patients with symptomatic coronary artery disease. The reference vessel diameter should closely match the scaffold nominal diameter. The treated lesion length should be less than the nominal scaffold length.

Product summary:

Device System Info:[Sterile Medical Device], sterile medical device by EO; Models: Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412526, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412529, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412527, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412530, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412528, Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium System - 412531

Authorization date:

2018-08-27